Dyadic International Inc (DYAI): Dyadic International’s CEO Mark Emalfarb...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	14
Posts	2855
Boards Moderated	0
Alias Born	12/23/2014

blue_skies

Re: None

Thursday, 02/10/2022 9:19:00 AM

Thursday, February 10, 2022 9:19:00 AM

Dyadic International’s CEO Mark Emalfarb to Present at BIO CEO & Investor Conference

https://finance.yahoo.com/news/dyadic-international-ceo-mark-emalfarb-133000477.html

Dyadic International, Inc.
Mon, February 7, 2022, 8:30 AM

JUPITER, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company’s CEO Mark Emalfarb will be presenting at the upcoming 2022 BIO CEO & Investor Conference being held at the Marriott Marquis New York City February 14th -15th, and virtually through the 17th.

Presentation Title, “Revolutionary C1 Protein Production Platform, Addressing Current Vaccine & Therapeutic Access & Affordability Using the Science of Tomorrow, Today”